Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Youcare Pharmaceutical Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 1/6
Youcare Pharmaceutical Group's earnings have been declining at an average annual rate of -17.6%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 7.4% per year. Youcare Pharmaceutical Group's return on equity is 2.7%, and it has net margins of 2.4%.
Anahtar bilgiler
-17.6%
Kazanç büyüme oranı
-22.7%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 10.9% |
| Gelir büyüme oranı | -7.4% |
| Özkaynak getirisi | 2.7% |
| Net Marj | 2.4% |
| Sonraki Kazanç Güncellemesi | 31 Oct 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Youcare Pharmaceutical Group (SHSE:688658) Takes On Some Risk With Its Use Of Debt
Sep 25
Investors Can Find Comfort In Youcare Pharmaceutical Group's (SHSE:688658) Earnings Quality
Aug 29Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Price Is Out Of Tune With Earnings
Aug 16Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 21There's Reason For Concern Over Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Massive 26% Price Jump
Mar 04Gelir ve Gider Dağılımı
Youcare Pharmaceutical Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 3,946 | 96 | 1,693 | 390 |
| 31 Mar 24 | 4,036 | 169 | 1,819 | 364 |
| 31 Dec 23 | 4,196 | 185 | 1,969 | 352 |
| 30 Sep 23 | 3,998 | 152 | 1,891 | 314 |
| 30 Jun 23 | 4,813 | 402 | 2,290 | 318 |
| 31 Mar 23 | 4,770 | 357 | 2,288 | 344 |
| 31 Dec 22 | 4,542 | 335 | 2,234 | 344 |
| 30 Sep 22 | 5,123 | 507 | 2,617 | 363 |
| 30 Jun 22 | 4,763 | 473 | 2,438 | 305 |
| 31 Mar 22 | 4,987 | 539 | 2,582 | 241 |
| 31 Dec 21 | 4,966 | 545 | 2,572 | 200 |
| 30 Sep 21 | 4,879 | 562 | 2,538 | 146 |
| 30 Jun 21 | 4,789 | 523 | 2,506 | 136 |
| 31 Mar 21 | 4,481 | 476 | 2,299 | 137 |
| 31 Dec 20 | 4,339 | 442 | 2,176 | 128 |
| 30 Sep 20 | 4,096 | 358 | 2,058 | 116 |
| 31 Dec 19 | 4,288 | 285 | 2,052 | 126 |
| 31 Dec 18 | 3,983 | 268 | 1,875 | 98 |
| 31 Dec 17 | 2,700 | 162 | 779 | 82 |
Kaliteli Kazançlar: 688658 has high quality earnings.
Büyüyen Kar Marjı: 688658's current net profit margins (2.4%) are lower than last year (8.4%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 688658's earnings have declined by 17.6% per year over the past 5 years.
Büyüme Hızlandırma: 688658's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: 688658 had negative earnings growth (-76%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-0.6%).
Özkaynak Getirisi
Yüksek ROE: 688658's Return on Equity (2.7%) is considered low.